Cytokinetics Will Provide An Update On Cardiac Myosin Modulation Programs And Global Commercial Launch Readiness For Aficamten At Its Investor And Analyst Day Today
Cytokinetics Will Provide An Update On Cardiac Myosin Modulation Programs And Global Commercial Launch Readiness For Aficamten At Its Investor And Analyst Day Today
Cytokinetics將在今天的投資者和分析師日更新心肌肌凝蛋白調節項目和全球商業推出準備情況
Cytokinetics Will Provide An Update On Cardiac Myosin Modulation Programs And Global Commercial Launch Readiness For Aficamten At Its Investor And Analyst Day Today
Cytokinetics將在今天的投資者和分析師日更新心肌肌凝蛋白調節項目和全球商業推出準備情況
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間